Psa: Oopsie! One Million Birth Control Pill Packets Recalled
- Replies 8
- Views 1.8k
- Created
- Last Reply
Top Posters In This Topic
-
Formerly Fluffy 3 posts
-
Lissa 2 posts
-
Malyss 2 posts
-
Tenshi 1 post
Popular Days
Featured Replies
Join the conversation
You can post as a guest; create a free account to track replies, follow topics, and be part of the largest weight loss surgery community.
Since pregnancy should be avoided the first year or 2 after WLS I wanted to share this article about the bc pill recall:
Well ain’t that some ****?! ONE MILLION PFIZER BIRTH CONTROL pills RECALLED! Hope you all didn’t plan on those really working!
Surprise!
One Million Birth Control Pill Packets Recalled
Filed under: Adverse Effects,Women’s Contraception,Women’s Health — Mike Mitka
Improper packaging of certain birth control pills manufactured by Pfizer and sold under the Akrimax Pharmaceuticals brand may leave women without adequate contraception, putting them at risk for unintended pregnancy. (Image: FDA)
Pfizer is withdrawing a reported 1 million packets of birth control pills because errors in how the pills were packaged may put women at risk for unintended pregnancy.
The company is recalling 14 lots each of Lo/Ovral-28 (norgestrel and ethinyl estradiol) Tablets and Norgestrel and Ethinyl Estradiol Tablets (generic), intended for customers in the US market. The tablets were manufactured and packaged by Pfizer and marketed by Akrimax Rx Products under the Akrimax Pharmaceuticals brand. These products are packaged in blister packs containing 21 tablets of active ingredients and 7 tablets of inert ingredients. Adequate contraception depends on a woman taking the proper pills in a designated sequence.
The products were distributed to warehouses, clinics, and retail pharmacies nationwide.
In an investigation, Pfizer found that some blister packs may not contain the proper number of inert or active ingredient tablets and that some of the tablets might be out of sequence. As a result, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception and at risk for unintended pregnancy. Pfizer said that women who took the recalled pills should begin using a nonhormonal form of contraception immediately and urged patients who have taken the recalled medications to notify their physicians and return any unused tablets to the pharmacy.
Any adverse events that may be related to the use of these products should be reported to Akrimax Medical Information at 1-877-509-3935 (8 AM to 7 PM Central standard time, Monday through Friday) or to the US food and Drug Administration’s MedWatch Program either online, by regular mail, or by fax. For regular mail, use the postage-paid, preaddressed Form FDA 3500; to fax, dial 1-800-FDA-0178 (1-800-332-0178).
Information about the lot numbers of the affected packets of birth control pills can be found here.